An Evolutionary Institute

Researchers at the Max Planck Institute of Evolutionary Anthropology (MPIEA) in Leipzig, Germany, recently concluded that differences in the expression patterns of genes distinguish humans from chimpanzees, though they share 98.7% of their DNA sequences.1 The team, led by geneticist Svante Pääbo, found that human expression patterns in the brain exhibited pronounced differences from those of chimpanzees and other apes, in effect, pointing to an accelerated rate of evolution of our ment

Written bySilvia Sanides
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The remarkable study received international coverage and drew attention to a young and energetic research institution that may play a leading international role in evolutionary anthropology. The MPIEA was founded in 1997 in the former East Germany as part of an attempt to create "a single research landscape," as the political catch phrase called it, in the reunited federation. Since reunification, 20 new Max Planck Institutes have been built in eastern Germany, bringing the total in Germany to 80.

The Leipzig institute employs 250, including 31 full-time scientists and 78 junior scientists and guest researchers. The total is expected to increase to 350 toward the end of the year, when the institute takes up residence in a new $33 million (US), 130,000-square-foot facility. Max Planck Institutes are largely publicly funded, with the German federal and provincial governments equally contributing 85% of the budgets. Membership fees and donations pay remaining costs. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies